Table 2.
Main effects models for association between the presence of MetS and current depressive symptom severity (total PHQ-9 scores), current depressive symptoms (yes/no), and antidepressant use.
| MetS (yes/no) | ||||
|---|---|---|---|---|
| Exposure group | OR (95% CI) | p-value | aOR (95% CI) | p-value |
| Total PHQ-9 scores1a | 1.05 (1.04, 1.06) | <0.001 | 1.04 (1.02, 1.05) | <0.001 |
| Antidepressant use - yes1b | 1.70 (1.46, 1.97) | <0.001 | 1.24 (1.03, 1.50) | 0.025 |
| Depressive symptoms - yes2a | 1.78 (1.51, 2.10) | <0.001 | 1.42 (1.17, 1.73) | 0.001 |
| Antidepressant use - yes2b | 1.70 (1.46, 1.97) | <0.001 | 1.31 (1.09, 1.57) | 0.004 |
OR unadjusted odds ratio, aOR adjusted odds ratio, CI confidence interval, the reference level for depressive symptoms is “no”. 1aCovariates in adjusted models include all 15 pre-selected covariates and antidepressant use. 1bCovariates in adjusted models include all 15 pre-selected covariates and depressive symptom severity (total PHQ-9 scores). 2aCovariates in adjusted models include all 15 pre-selected covariates and antidepressant use. 2bCovariates in adjusted models include all 15 pre-selected covariates and depressive symptoms (yes/no). p-values < 0.05 denote statistical significance.